|
Charles and Mary Ferkel Professor of Chemistry, Materials Science, and Applied Physics and Director of Materials and Process Simulation Center, California Institute of Technology William Goddard, Ph.D., received his B.S. degree with Hightest Honors from the University of California, Los Angles, and his Ph.D. in Engineering Science (with a minor in Physics) from the California Institute of Technology (CalTech). Since 1978, Dr. Goddard has had a distinguished career at CalTech, with appointments to the position of Professor of Chemistry and Applied Physics and Professor of Theoretical Chemistry. He has been Director of both the National Science Foundation (NSF) Materials Research Group and the NSF Grand Challenge Application Group at CalTech. Since 1990, Dr. Goddard has served as Director of Materials and Process Simulation Center (MSC) at Caltech and, since 2001 he has been the Charles and Mary Ferkel Professor of Chemistry, Materials Science and Applied Physics. Dr. Goddard has authored more than 735 research publications and currently receives research funding from leading government and industry organizations, including: NSF, National Institutes of Health, Department of Energy, Defense Advanced Research Projects Agency, Army Research Office, Office of Naval Research, Environmental Protection Agency, Chevron, Intel Corp., Dow-Corning, Pfizer, Boehringer-Ingelheim and Allozyne. Dr. Goddard has received numerous awards and honors, including: the American Chemical Society Award for Computers in Chemistry (1988), the Feynman Prize for Nanotechnology Theory (1999), the American Chemical Society Award for Theoretical Chemistry (2007) and the NASA Space Sciences Award (2000 and 2007). He has served as a consultant to diverse multinational companies, including: General Electric, General Motors, Shell Development, BP, Exxon, Chevron, Dow Chemical, AT&T Bell Labs, Union Carbide, 3M, Proctor and Gamble, Dow Corning and Nissan. Dr. Goddard also has co-founded five companies: Molecular Simulations Inc. (now Accelrys), Schrödinger Inc., Eidogen Inc. (now Eidogen-Sertanty), Systine Inc. and, most recently, Allozyne Inc. | 